Cargando…
LTP-1, a novel antimitotic agent and Stat3 inhibitor, inhibits human pancreatic carcinomas in vitro and in vivo
Pancreatic cancer is the leading cause of cancer death worldwide with a poor survival rate. The objective of this study was to determine the mechanism of action of a novel antimitotic and Stat3 inhibitor, LTP-1, on human pancreatic cancer in vitro and in vivo. We found that LTP-1 inhibited pancreati...
Autores principales: | Huang, Han-Li, Chao, Min-Wu, Chen, Chung-Chun, Cheng, Chun-Chun, Chen, Mei-Chuan, Lin, Chao-Feng, Liou, Jing-Ping, Teng, Che-Ming, Pan, Shiow-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899784/ https://www.ncbi.nlm.nih.gov/pubmed/27278358 http://dx.doi.org/10.1038/srep27794 |
Ejemplares similares
-
Photopharmacology of Antimitotic Agents
por: Kirchner, Susanne, et al.
Publicado: (2022) -
Molecular mechanisms underlying the antitumor activity of (E)-N-hydroxy-3-(1-(4-methoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-6-yl)acrylamide in human colorectal cancer cells in vitro and in vivo
por: Chen, Chun-Han, et al.
Publicado: (2015) -
α-Tomatine-Mediated Anti-Cancer Activity In Vitro and In Vivo through Cell Cycle- and Caspase-Independent Pathways
por: Chao, Min-Wu, et al.
Publicado: (2012) -
Re-investigating PLK1 inhibitors as antimitotic agents
por: Delacour, Quentin, et al.
Publicado: (2017) -
MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancer
por: Huang, Han-Li, et al.
Publicado: (2016)